Internal Medicine, Hematology & Oncology · Dallas, TX
NPI
1851350979
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5323 Harry Hines Blvd
Dallas, TX, 75390
Phone (214) 645-8600
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
396 services
Medicare patients, 2024
146
Average age 74
Drug cost, 2024
$2.5M
675 prescriptions
Company payments, 2025
$0
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert H Collins Jr. was code 99214 (office e&m - established), 116 times for 79 patients. In total Robert H Collins Jr. billed 396 services in 12 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 116 | 79 | $73.81 | $8,562 |
| 99233 Hospital E&M - Subsequent | Facility | 96 | 22 | $91.87 | $8,820 |
| 99214 Office E&M - Established | Office | 62 | 52 | $65.25 | $4,045 |
| 99215 Office E&M - Established | Facility | 58 | 25 | $111.30 | $6,456 |
| 99215 Office E&M - Established | Office | 37 | 20 | $96.96 | $3,588 |
By year: 2022 $75K for 922 services; 2023 $35K for 432 services; 2024 $34K for 396 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert H Collins Jr. prescribed most often to Medicare patients was Acyclovir, with 124 prescriptions and refills. In total Robert H Collins Jr. wrote 675 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 124 | 231 | 33 | $2,233 |
| Calquence Acalabrutinib Maleate | 46 | 46 | Under 11 | $666K |
| Venclexta Venetoclax | 44 | 44 | Under 11 | $368K |
| Allopurinol Generic | 41 | 71 | 14 | $402 |
| Bosulif Bosutinib | 33 | 33 | Under 11 | $614K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 21 | 26 | Under 11 | $73.55 |
| Imatinib Mesylate Generic | 18 | 20 | Under 11 | $20K |
| Posaconazole Generic | 14 | 14 | Under 11 | $17K |
| Sprycel Dasatinib | 14 | 16 | Under 11 | $133K |
| Penicillin V Potassium Generic | 13 | 37 | Under 11 | $305 |
| Valacyclovir Valacyclovir Hcl | 13 | 33 | Under 11 | $1,248 |
| Prednisone Generic | 13 | 14 | Under 11 | $42.3 |
| Gleevec Imatinib Mesylate | 13 | 13 | Under 11 | $108K |
| Pantoprazole Sodium Generic | 12 | 30 | Under 11 | $92.99 |
| Montelukast Sodium Generic | 12 | 32 | Under 11 | $124 |
Brand drugs: 194 claims; generic drugs: 481 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert H Collins Jr. $0 (- in general payments such as food, travel and fees) from 1 company.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.